Advertisement
Telegram ads for your business · TCA Media
Monday, 16 November 2026
The main stories.
Advertisement
Telegram ads for your business · TCA Media
Society

Infections with consequences that may appear years later: what is important to know

Epidemiologist Manar Smagul explained that some infections can persist in the body for years and increase the risk of certain diseases, including cancer.

09 Nov, 15:51Read in Russian

Manar Smagul explained that long-term consequences may be associated with hepatitis B and C viruses, HPV, Epstein-Barr virus, herpesvirus type 8, Helicobacter pylori, and HIV. The risk depends on the duration of the infection, the state of the immune system, and chronic inflammation, so the presence of an infection does not necessarily mean the development of cancer.

According to Smagul, in rare cases after measles, the virus can persist in the tissues of the central nervous system. Then, after 7–10 years, behavioral changes, memory and motor function impairments, and seizures may appear; the disease can progress to coma and fatal outcome.

Chronic infections caused by hepatitis B and C viruses can gradually damage the liver and increase the risk of cirrhosis and liver cancer. The prolonged presence of high-risk HPV is associated with precancerous changes and certain types of cancer, including cervical cancer. However, HPV often proceeds without symptoms, and in most cases, the body copes with the infection on its own.

Advertisement
Telegram ads for your business · TCA Media

There is currently no specific treatment that would eliminate HPV from the body. Medical assistance for such an infection is aimed at identifying and treating changes that may occur with its prolonged persistence. The doctor considers regular monitoring, screening, vaccination, and consulting a specialist for verified information important.

Vaccination against hepatitis B and measles helps reduce the risk of infection and complications. The HPV vaccine is intended for the prevention of future diseases, not for treating an existing infection. According to WHO data, by the end of 2025, HPV vaccination had been included in the national programs of 165 countries; Kazakhstan added it to the national immunization schedule in 2024.